Ma, G., Allen, T. J., Cooper, M. E., & Cao, Z. (2004). Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes. Kidney international, 66(3), 1090-1098. https://doi.org/10.1111/j.1523-1755.2004.00859.x
Chicago Style (17th ed.) CitationMa, Guorong, Terri J. Allen, Mark E. Cooper, and Zemin Cao. "Calcium Channel Blockers, Either Amlodipine or Mibefradil, Ameliorate Renal Injury in Experimental Diabetes." Kidney International 66, no. 3 (2004): 1090-1098. https://doi.org/10.1111/j.1523-1755.2004.00859.x.
MLA (9th ed.) CitationMa, Guorong, et al. "Calcium Channel Blockers, Either Amlodipine or Mibefradil, Ameliorate Renal Injury in Experimental Diabetes." Kidney International, vol. 66, no. 3, 2004, pp. 1090-1098, https://doi.org/10.1111/j.1523-1755.2004.00859.x.